ID | 440 |
No | 440 |
Brand Name | BEZARTAN TABLET 300 MG |
Ingredients | IRBESARTAN 300 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | PVDC-BLISTER |
Storage | STORE AT THE TEMPERATURE BELOW 30 C AND PROTECT FROM LIGHT |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | PRESCRIPTION |
ATC Classification | C09CA04 |
Pharmaceutical Class | ANTIHYPERTENSIVE |
Indications | TREATMENT OF ESSENTIAL HYPERTENSION, TREATMENT OF DIABETIC NEPHROPATHY WITH AN ELEVATED SERUM CREATININE AND PROTEINURIA (>300 MG/DAY) IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION |
Contraindications | HYPERSENSITIVITY, SECOND AND THIRD TRIMESTER OF PREGNANCY, WITH ALISKIREN-CONTAINING PRODUCT IN PATIENTS WITH DIABETE MELLITUS OR RENAL IMPAIREMENT |
Side Effects | HYPERKALAEMIA, DIZZINESS, ORTHOSTATIC DIZZINESS, NAUSEA, MUSCULOSKELETAL PAIN, FATIQUE |
Unit Price | |
EDL |
No |
Description | WHITE, OVAL-SHAPED, WITH SCORED ON ONE SIDE AND FILM COATED TABLET. |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | DUOPHARMA MANUFACTURING(BANGI)SDN.BHD. |
Country | MALAYSIA |
Import Registration No | MAL19056120AZ |
Import Registration Date | 2019-05-30 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-12-03 |
FDD Registration No | 04 I 5476/23 |
FDD Registration Date | 2023-04-25 |
Expiry Date | 2026-04-24 |